InvestorsHub Logo
Followers 4834
Posts 168875
Boards Moderated 1
Alias Born 02/21/2011

Re: None

Saturday, 12/01/2018 7:59:21 AM

Saturday, December 01, 2018 7:59:21 AM

Post# of 1509
to short a biotech Company who close a R/M and trading 50% less cash value is not a good idea. SQUEEZE pending + R/M updates + pipeline from new Company... EDGE fast $5 $6 short term imho. extremly undervalued. huge jump ahead.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.